{"text": ["Novartis", "Tafinlar\u00ae", "+", "Mekinist\u00ae", "demonstrates", "long-term,", "relapse-free", "survival", "benefit", "for", "high-risk,", "stage", "III", "melanoma", "patients", "in", "study", "published", "in", "NEJM"], "created_at": "2020-09-16 21:02:00"}
{"text": ["Novartis", "US", "Foundation", "commits", "$25M", "to", "improve", "health", "equity", "by", "reducing", "health", "disparities", "in", "the", "US"], "created_at": "2020-09-16 18:00:00"}
{"text": ["Novartis", "reinforces", "commitment", "to", "patient", "access,", "pricing", "a", "EUR", "1.85", "billion", "sustainability-linked", "bond"], "created_at": "2020-09-16 14:24:00"}
{"text": ["Technical", "Assessment:", "Bullish", "in", "the", "Intermediate-Term"], "created_at": "2020-09-16 00:00:00"}
